GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cogstate Ltd (OTCPK:COGZF) » Definitions » Valuation Rank

COGZF (Cogstate) Valuation Rank


View and export this data going back to 2010. Start your Free Trial

What is Cogstate Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Cogstate Valuation Rank Related Terms

Thank you for viewing the detailed overview of Cogstate's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Cogstate Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cogstate Ltd (OTCPK:COGZF) » Definitions » Valuation Rank
Comparable Companies
ASX:ONE ASX:ALC ASX:M7T ASX:AYA ASX:PCK ASX:BMT ASX:SHG ASX:MDR ASX:PHX ASX:BB1 VEEV GEHC ASX:PME DOCS TEM TSE:2413 HQY WAY SZSE:300253 HKSE:02228
Traded in Other Exchanges
CGS:Australia
Address
161 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Website
https://www.cogstate.com
Cogstate Ltd is a cognitive science company. The principal activity of the group is Creation, validation and commercialisation of digital brain health assessments; and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.